Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTC-DOX for Liver Metastases
NCT00041808Phase 2Completed
- Sponsor
- FeRx
- Start
- Jul 2001
- Modality
- Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of MTC-doxorubicin in liver metastases, sponsored by FeRx. Started Jul 2001; status: completed.
02
Drugs
MTC-doxorubicin
03
Conditions
liver metastases
Beyond the preview
Go deeper on NCT00041808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041808.